For patients with diabetes, the challenge of managing their therapy can be alleviated with proper, quality education. For more than a decade, Novasyte has partnered with many of the largest, global medical device, diagnostic, and pharmaceutical organizations, providing specialized education with the highest-quality certified product trainers.
With increased pressures to reduce internal SG&A costs, accelerate the pace of business, and increase process efficacies, manufacturers are continually investing in third-party partnerships where innovation is at the forefront of service delivery.
Improving the patient experience and measuring their satisfaction is becoming increasingly
important to facilities and manufacturers. Not only is patient satisfaction one of the three essential dimensions of the Institute for Health Improvement (IHI) Triple Aim, but the scores are also key performance metrics under the 2016 Center for Medicare and Medicaid Services (CMS) Hospital Value-Based Purchasing (VBP) Program.
Pharmaceutical manufacturers today are facing increasing pressures from The Trump Administration to reduce the cost of drug prices.
Announced on Wednesday of this week, Novartis indicated they would not be raising prices on its products for the remainder of 2018.1 They are joining Pfizer, whose chief executive officer, Ian Read, announced on July 10 that the company would delay increasing the prices on dozens of drug products until 2019, following President Trump publicly spotlighting the firm the day prior.2
This follows the initial statement from The Trump Administration in May 2018 regarding a comprehensive blueprint strategy to lower drug prices.
As a partner to many of the largest, global medtech companies for more than a decade, Novasyte has gained a strong understanding of the evolving healthcare landscape and trends in nurse staffing. With the consistent rotation of nurses in hospital systems, manufacturers are adapting to the staffing changes and optimizing their education methods to ensure successful medical device conversions.
For many medtech manufacturers, commercializing products into a new healthcare facility brings a series of opportunities and challenges, including:
- The need to provide proof of product efficacy and cost effectiveness,
- The need to deliver new product into the facility quickly,
- The need to align with facility leadership on the strategic direction to implement, and
- The need to train the facility’s end-users to support adoption.
In May 2018, the FDA released a report titled "FDA Report on the Quality, Safety and Effectiveness of Servicing of Medical Devices," issued by the Secretary of Health and Human Services and in accordance with The Food and Drug Administration Reauthorization Act (FDARA). The FDA examined product servicing by manufacturers, healthcare establishments and third-party providers who refurbish, recondition, rebuild, remarket, service and repair medical devices.
Topics: Med-Tech Industry Update, Quality Management System, Medical Device Industry, Medical Device Field Action, San Diego, CA, Industry Trends, ISO Certification, Industry Advancements, Field Technical
The importance of providing and fearlessly seeking feedback at Novasyte goes back to the Company's inception in 2008. This cultural priority is not simply a theory discussed at the annual company meeting, but a living, breathing, organically-developed reality of the day-to-day environment that allows for cross-departmental synergies to develop, relationships to grow, and issues to be resolved in real-time.
On April 30, 2018, the California Supreme Court unanimously ruled to establish clearer distinctions between W-2 employees and 1099 independent contractors. Additionally, they made the process more difficult for employers to classify an employee as an independent contractor through an updated, more restrictive "ABC" test.
Organizations who have previously struggled with managing a recall internally, or perhaps do not have the time or resources to maintain the consignee data, develop a field strategy or create a centralized database, can trust Novasyte as their recall management partner.
Topics: Medical Device Recall, Med-Tech Industry Update, Medical Device Industry, Medical Device Field Action, S.M.A.R.T Programs, Industry Trends, Industry Advancements, SMART recall program, White Paper